Back to top
more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$72.82 USD

72.82
583,100

-0.39 (-0.53%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $72.83 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Henry Schein (HSIC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Henry Schein (HSIC) closed the most recent trading day at $80.90, moving +1.2% from the previous trading session.

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

by Zacks Equity Research

Investors are optimistic about Henry Schein (HSIC) due to the performance of its dental business.

Henry Schein (HSIC) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Henry Schein (HSIC) closed at $78.90, marking a -1.02% move from the previous day.

Henry Schein (HSIC) Stock Moves -0.17%: What You Should Know

by Zacks Equity Research

Henry Schein (HSIC) closed the most recent trading day at $77.89, moving -0.17% from the previous trading session.

Henry Schein (HSIC) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Henry Schein (HSIC) closed at $76.01 in the latest trading session, marking a +0.62% move from the prior day.

Why Is Henry Schein (HSIC) Down 1.3% Since Last Earnings Report?

by Zacks Equity Research

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Henry Schein (HSIC) Stock Moves -0.15%: What You Should Know

by Zacks Equity Research

Henry Schein (HSIC) closed the most recent trading day at $75.26, moving -0.15% from the previous trading session.

Here's Why Investors Should Retain Henry Schein (HSIC) for Now

by Zacks Equity Research

Henry Schein (HSIC) is expected to witness a favorable share price movement, led by optimism surrounding the performance of the dental business and strategic buyouts.

Henry Schein (HSIC) Q1 Earnings Miss, Operating Margin Dips

by Zacks Equity Research

Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.

Henry Schein (HSIC) Q1 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Henry Schein (HSIC) delivered earnings and revenue surprises of -2.42% and 1.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Henry Schein (HSIC)

by Zacks Equity Research

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Becton Dickinson (BDX) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Becton Dickinson (BDX) delivered earnings and revenue surprises of 4% and 3.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Henry Schein (HSIC) Stock Moves -0.58%: What You Should Know

by Zacks Equity Research

Henry Schein (HSIC) closed the most recent trading day at $80.01, moving -0.58% from the previous trading session.

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Is a Beat Likely for Cardinal Health (CAH) in Q3 Earnings?

by Zacks Equity Research

Cardinal Health's (CAH) third-quarter fiscal 2023 results are expected to reflect solid performance in the Pharmaceutical segment. However, inflationary pressure is likely to have continued.

Embecta (EMBC) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Embecta's (EMBC) diabetes care business is expected to have progressed in the fiscal second quarter banking on strong execution of its three strategic pillars.

Charles River (CRL) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research

Continued global demand for research models and associated services are likely to have driven Charles River's (CRL) Q1 revenues.

Alcon (ALC) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Amid persistent supply-chain headwinds, Alcon's (ALC) first-quarter top-line results are likely to reflect the commercial execution of new product launches across its segments and contributions from strategic alliances.

What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) first-quarter 2023 results are likely to reflect strong performance in the Technologies & Equipment business.

AMN Healthcare (AMN) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

AMN Healthcare's (AMN) first-quarter results are likely to reflect soft demand across its segments.

Henry Schein (HSIC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Henry Schein (HSIC) closed at $81.19 in the latest trading session, marking a -0.02% move from the prior day.

Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down

by Zacks Equity Research

Quest Diagnostics (DGX) base business registers growth in the first quarter of 2023.

Integra's (IART) Q1 Earnings Match Estimates, Margins Contract

by Zacks Equity Research

In CSS, Integra (IART) witnesses a good start to the year with double-digit growth in the CUSA product line and programmable valves as well as strong performance in instrument sales.

Edwards Lifesciences (EW) Q1 Earnings Top Estimates, '23 View Up

by Zacks Equity Research

Edwards Lifesciences (EW) continues to register strong momentum in TMTT, led by the continued adoption of the PASCAL Precision system in Europe.

Lamb Weston and TTEC Holdings have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Lamb Weston and TTEC Holdings have been highlighted as Zacks Bull and Bear of the Day.